Free Trial
NASDAQ:APLT

Applied Therapeutics (APLT) Stock Price, News & Analysis

Applied Therapeutics logo
$0.34 0.00 (-0.38%)
Closing price 07/3/2025 03:50 PM Eastern
Extended Trading
$0.34 0.00 (-0.30%)
As of 07/3/2025 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Applied Therapeutics Stock (NASDAQ:APLT)

Key Stats

Today's Range
$0.32
$0.35
50-Day Range
$0.30
$0.60
52-Week Range
$0.30
$10.62
Volume
1.86 million shs
Average Volume
3.43 million shs
Market Capitalization
$47.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.10
Consensus Rating
Moderate Buy

Company Overview

Applied Therapeutics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
76th Percentile Overall Score

APLT MarketRank™: 

Applied Therapeutics scored higher than 76% of companies evaluated by MarketBeat, and ranked 237th out of 929 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Applied Therapeutics has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 3 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Applied Therapeutics has only been the subject of 1 research reports in the past 90 days.

  • Read more about Applied Therapeutics' stock forecast and price target.
  • Earnings Growth

    Earnings for Applied Therapeutics are expected to grow in the coming year, from ($0.65) to ($0.62) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Applied Therapeutics is -0.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Applied Therapeutics is -0.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Applied Therapeutics has a P/B Ratio of 0.69. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Applied Therapeutics' valuation and earnings.
  • Percentage of Shares Shorted

    15.31% of the float of Applied Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Applied Therapeutics has a short interest ratio ("days to cover") of 9.9.
  • Change versus previous month

    Short interest in Applied Therapeutics has recently increased by 18.43%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Applied Therapeutics does not currently pay a dividend.

  • Dividend Growth

    Applied Therapeutics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    15.31% of the float of Applied Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Applied Therapeutics has a short interest ratio ("days to cover") of 9.9.
  • Change versus previous month

    Short interest in Applied Therapeutics has recently increased by 18.43%, indicating that investor sentiment is decreasing significantly.
  • Search Interest

    Only 2 people have searched for APLT on MarketBeat in the last 30 days. This is a decrease of -60% compared to the previous 30 days.
  • MarketBeat Follows

    5 people have added Applied Therapeutics to their MarketBeat watchlist in the last 30 days. This is an increase of 150% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Applied Therapeutics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.60% of the stock of Applied Therapeutics is held by insiders.

  • Percentage Held by Institutions

    98.31% of the stock of Applied Therapeutics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Applied Therapeutics' insider trading history.
Receive APLT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Applied Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

APLT Stock News Headlines

Applied Therapeutics, Inc. (APLT) - Yahoo Finance
Banks aren’t ready for this altcoin—are you?
Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly positioned to fill it…
See More Headlines

APLT Stock Analysis - Frequently Asked Questions

Applied Therapeutics' stock was trading at $0.8562 at the start of the year. Since then, APLT shares have decreased by 60.6% and is now trading at $0.3370.

Applied Therapeutics Inc. (NASDAQ:APLT) announced its quarterly earnings results on Monday, April, 14th. The company reported ($0.24) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.18) by $0.06. The company earned $0 million during the quarter, compared to analyst estimates of $0.61 million.

Applied Therapeutics (APLT) raised $60 million in an initial public offering (IPO) on the week of May 13th 2019. The company issued 4,000,000 shares at a price of $14.00-$16.00 per share. Citigroup, Cowen and UBS Investment Bank served as the underwriters for the IPO and Baird was co-manager.

Shares of APLT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Applied Therapeutics investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Adobe (ADBE), Arista Networks (ANET), Advanced Micro Devices (AMD) and ServiceNow (NOW).

Company Calendar

Last Earnings
4/14/2025
Today
7/05/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:APLT
Fax
N/A
Employees
30
Year Founded
2017

Price Target and Rating

Average Stock Price Target
$6.10
High Stock Price Target
$14.00
Low Stock Price Target
$1.50
Potential Upside/Downside
+1,710.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
6 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$105.62 million
Pretax Margin
-16,357.52%

Debt

Sales & Book Value

Annual Sales
$460 thousand
Price / Cash Flow
N/A
Book Value
$0.49 per share
Price / Book
0.69

Miscellaneous

Free Float
139,311,000
Market Cap
$47.71 million
Optionable
Optionable
Beta
1.82

Social Links

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:APLT) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners